Literature DB >> 18081228

Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors.

Hui Ying Zhang1, De Wu Han, Ai Rong Su, Li Tong Zhang, Zhong Fu Zhao, Jing Quan Ji, Bao Hong Li, Cheng Ji.   

Abstract

AIM: To characterize the correlation between severity of hepatopulmonary syndrome (HPS) and degree of hepatic dysfunction, and to explore how intestinal endotoxemia (IETM) affects the development of HPS in cirrhotic rats.
METHODS: Male Wister rats were fed with a diet containing maize flour, lard, cholesterol, and alcohol and injected subcutaneously with CCl(4) oil solution every two days for 8 wk to induce typical cirrhosis and development of HPS. The animals were also given a nitric oxide (NO) production inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME) intraperitoneally, and an iNOS inhibitor, aminoguanidine hydrochloride (AG) via gavage daily from the end of the 4th wk to the end of the 6th or 8th wk, or a HO-1 inhibitor, zinc protoporphyrin (ZnPP) intraperitoneally 12 h prior to killing. Blood, liver and lung tissues were sampled.
RESULTS: Histological deterioration of the lung paralleled to that of the liver in the cirrhotic rats. The number of pulmonary capillaries was progressively increased from 6.1 +/- 1.1 (count/filed) at the 4th wk to 14.5 +/- 2.4 (count/filed) at the 8th wk in the cirrhotic rats. Increased pulmonary capillaries were associated with increased blood levels of lipopolysaccharide (LPS) (0.31 +/- 0.08 EU/mL vs control 0.09 +/- 0.03 EU/mL), alanine transferase (ALT, 219.1 +/- 17.4 U/L vs control 5.9 +/- 2.2 U/L) and portal vein pressure. Compared with normal control animals, the number of total cells in bronchoalveolar lavage fluid (BALF) of the cirrhotic rats at the 8th wk was not changed, but the number of macrophages and the ratio of macrophages to total cells were increased by nearly 2-fold, protein expression of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) started to increase significantly at the 4th wk, and reached its peak at the 8th wk in the lung of cirrhotic rats. The increase of iNOS expression appeared to be quicker than that of eNOS. NO(2)(-)/NO(3)(-) was also increased, which was correlated to the increase of iNOS (r = 0.7699, P < 0.0001) and eNOS (r = 0.5829, P < 0.002). mRNA expression of eNOS and iNOS was highly consistent with their protein expression.
CONCLUSION: Progression and severity of HPS as indicated by both increased pulmonary capillaries and histological changes are closely associated with LPS levels and progression of hepatic dysfunction as indicated by increased levels of ALT and portal vein pressure. Intestinal endotoxemia plays a central role in the development of HPS in the cirrhotic rat model by inducing NO and/or CO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081228      PMCID: PMC4205458          DOI: 10.3748/wjg.v13.i47.6385

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  57 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

Review 2.  Pulmonary-Hepatic vascular Disorders (PHD).

Authors:  R Rodríguez-Roisin; M J Krowka; Ph Hervé; M B Fallon
Journal:  Eur Respir J       Date:  2004-11       Impact factor: 16.671

3.  Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney.

Authors:  F Wu; F Park; A W Cowley; D L Mattson
Journal:  Am J Physiol       Date:  1999-06

4.  Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome.

Authors:  Miguel R Arguedas; Britt B Drake; Ashwani Kapoor; Michael B Fallon
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb2 lymphoma cells.

Authors:  P R Murphy; M Limoges; F Dodd; R T Boudreau; C K Too
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

6.  Methylene blue improves the hepatopulmonary syndrome.

Authors:  P Schenk; C Madl; S Rezaie-Majd; S Lehr; C Müller
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

7.  Hypoxaemia and liver cirrhosis: a new argument in favour of a "diffusion-perfusion defect".

Authors:  J B Thorens; A F Junod
Journal:  Eur Respir J       Date:  1992-06       Impact factor: 16.671

8.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

9.  Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung.

Authors:  P W Shaul; A J North; T S Brannon; K Ujiie; L B Wells; P A Nisen; C J Lowenstein; S H Snyder; R A Star
Journal:  Am J Respir Cell Mol Biol       Date:  1995-08       Impact factor: 6.914

10.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Authors:  G Melillo; T Musso; A Sica; L S Taylor; G W Cox; L Varesio
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  16 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

2.  Glucose-regulated protein 78 may play a crucial role in promoting the pulmonary microvascular remodeling in a rat model of hepatopulmonary syndrome.

Authors:  Huiying Zhang; Minli Lv; Zhongfu Zhao; Jiantao Jia; Lili Zhang; Peng Xiao; Limin Wang; Chen Li; Jingquan Ji; Xiaoxia Tian; Xujiong Li; Yimin Fan; Lina Lai; Yan Liu; Baohong Li; Cuiying Zhang; Mingshe Liu; Jianhong Guo; Dewu Han; Cheng Ji
Journal:  Gene       Date:  2014-04-21       Impact factor: 3.688

Review 3.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

5.  Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB.

Authors:  Hui Yang; Long-Feng Zhao; Zhong-Fu Zhao; Yan Wang; Jing-Jing Zhao; Li Zhang
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

6.  Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients.

Authors:  Georgios N Kalambokis; Athanasia Mouzaki; Maria Rodi; Konstantinos Pappas; Panagiotis Korantzopoulos; Epameinondas V Tsianos
Journal:  Hepatol Int       Date:  2012-02-02       Impact factor: 6.047

7.  Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Bo Jin; Xu-Jun He; Qin Zhang; Wei-Ming Zhou; Wen-Juan Xu; Huo-Xiang Lu
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 8.  Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.

Authors:  Sarah Raevens; Michael B Fallon
Journal:  Hepatology       Date:  2018-11       Impact factor: 17.425

9.  Hepatopulmonary syndrome: the role of intra-abdominal hypertension and a novel mouse model.

Authors:  Zhaojie Zhang; Xiaolong Qi; Zhiwei Li; Lijun Xu; Fei Wang; Shenglan Wang; Yizhong Chang; Wanrong Ma; Mingxin Xu; Changqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  The effects of flavanoid on the treatment of hepatopulmonary syndrome.

Authors:  Talha Atalay; Murat Cakir; Ahmet Tekin; Tevfik Kucukkartallar; Suleyman Kargin; Adil Kartal; Adnan Kaynak
Journal:  J Korean Surg Soc       Date:  2013-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.